Alfa Laval and Lund University, one of Scandinavia's oldest and most prestigious academic institutions, have formalized a new strategic partnership to strengthen collaboration, drive innovation, and ...

These shifts are forcing winemakers to rethink one of the oldest assumptions in their craft: terroir, the delicate interplay of soil, sun, wind, rain and human touch that gives each wine its specific ...

Scientists found that gluten is key to spaghetti’s strength, acting like a microscopic safety net that prevents ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual event featuring two distinguished ...

Canada will accelerate mining projects worth C$6.4 billion ($4.6 billion), as part of the Critical Minerals Production ...

Imlifidase successfully met primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation. First clinical data supports imlifidase ability ...

Pregnancies do not weaken a woman's skeleton. Breastfeeding, however, can reduce bone density considerably. These are ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced its interim report for January-September 2025.

Bioadaptor was designed to restore normal vessel function and reduce late stent-related complications. It’s working so far.

An international team of researchers led by the Leibniz Institute for Astrophysics Potsdam (AIP) has shed light on a ...

MANILA, Philippines — Quezon City and Dumaguete City are among the new member cities of the UNESCO Creative Cities Network.

Xintela (XINT) announces that the last patient has been dosed in the company's clinical Phase I/IIa study with XSTEM® in patients with difficult-to-heal venous leg ulcers. XSTEM, which consists of all ...